Disclosure Quest - Search SEC Filings

Name	Type of Offering	Accepted Date
Pear Therapeutics, Inc. See All Filings	D/A	2021-03-02 16:09:20 UTC
Amount To Be Raised $131,999,923 Associated Brokers / Dealers N/A CIK Number 0001615898 Filed Document 0001615898-21-000001 Exclusions or Exemptions 506b Accepted Date 2021-03-02 16:09:20 UTC Type of Offering D/A Industry Other Health Care Principal Place of Business MASSACHUSETTS Revenue or Assets Decline to Disclose Type of Security Equity
Pear Therapeutics, Inc. See All Filings	D	2020-12-18 12:44:34 UTC
Amount To Be Raised $111,999,925 Associated Brokers / Dealers N/A CIK Number 0001615898 Filed Document 0001615898-20-000002 Exclusions or Exemptions 506b Accepted Date 2020-12-18 12:44:34 UTC Type of Offering D Industry Other Health Care Principal Place of Business MASSACHUSETTS Revenue or Assets Decline to Disclose Type of Security Equity
Pear Therapeutics, Inc. See All Filings	D	2019-01-04 10:55:09 UTC
Amount To Be Raised $64,999,912 Associated Brokers / Dealers N/A CIK Number 0001615898 Filed Document 0001615898-19-000001 Exclusions or Exemptions 506b Accepted Date 2019-01-04 10:55:09 UTC Type of Offering D Industry Other Health Care Principal Place of Business MASSACHUSETTS Revenue or Assets Decline to Disclose Type of Security Equity
Pear Therapeutics, Inc. See All Filings	D	2018-01-12 09:57:19 UTC
Amount To Be Raised $50,999,997 Associated Brokers / Dealers N/A CIK Number 0001615898 Filed Document 0001615898-18-000001 Exclusions or Exemptions 506b Accepted Date 2018-01-12 09:57:19 UTC Type of Offering D Industry Other Health Care Principal Place of Business MASSACHUSETTS Revenue or Assets Decline to Disclose Type of Security Equity
Pear Therapeutics, Inc. See All Filings	D	2016-02-08 00:00:00 UTC
Amount To Be Raised $20,422,072 Associated Brokers / Dealers N/A CIK Number 0001615898 Filed Document 0001615898-16-000001 Exclusions or Exemptions 506b Accepted Date 2016-02-08 00:00:00 UTC Type of Offering D Industry Biotechnology Principal Place of Business MASSACHUSETTS Revenue or Assets Decline to Disclose Type of Security Equity